-+ 0.00%
-+ 0.00%
-+ 0.00%

Arrowhead Pharmaceuticals Price Target Raised to $120.00/Share From $100.00 by Morgan Stanley

Dow Jones·07/23/2026 18:10:00

Please log in to view news